{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:36:58Z","timestamp":1789087018763,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010463","name":"Institut Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010463","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Equipe labellis\u00e9e Ligue Nationale contre le Cancer"},{"DOI":"10.13039\/501100004097","name":"Fondation ARC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008017","name":"Gustave Roussy","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008017","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CNRS"},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","award":["21CQ016-00"],"award-info":[{"award-number":["21CQ016-00"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canceropole Ile de France"},{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris Saclay","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ITMO Cancer"},{"name":"INCA"},{"name":"R\u00e9gion Ile de France","award":["NEX061034"],"award-info":[{"award-number":["NEX061034"]}]},{"name":"SIRIC Curie \/ INCa-DGOS-Inserm-ITMO Cancer","award":["18000"],"award-info":[{"award-number":["18000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    During their inevitable evolution towards acquired resistance to anti-cancer targeted therapies, cancer cells adopt distinct gene expression profiles that allow them to transiently adapt to and tolerate the treatment. Cancer cells surviving therapy can increase their mutation rate, enhancing the likelihood of acquiring resistance-conferring mutations and evolving into resistant cells. Here we show that translational control mediates the adaptive mutability of melanoma drug-tolerant cells by regulating the translation of the error-prone non-homologous end joining (NHEJ) component\n                    <jats:italic>53BP1<\/jats:italic>\n                    . The specific inhibition of 5\u2019UTR-driven\n                    <jats:italic>53BP1<\/jats:italic>\n                    mRNA translation was sufficient to impair NHEJ and mutability. We found that the eIF4A RNA helicase, regulates\n                    <jats:italic>53BP1<\/jats:italic>\n                    mRNA translation. Consequently, targeting the eIF4A with two small molecule inhibitors significantly delays the acquisition of resistance to combination of BRAF and MEK inhibitors in BRAF\n                    <jats:sup>V600<\/jats:sup>\n                    -mutant melanoma xenograft models and cell lines by reducing the mutability of drug-tolerant cells. Our results demonstrate that a standard-of-care therapy for melanoma, by engaging non-genetic adaptation driven at the translational level, contributes to the evolution of drug-tolerant melanoma cells toward acquired resistance.\n                  <\/jats:p>","DOI":"10.1038\/s44321-026-00479-5","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:39:19Z","timestamp":1784554759000},"page":"3278-3317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Selective mRNA translation determines adaptative mutability of melanoma cells to anti-BRAF\/MEK combination therapy"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2928-3983","authenticated-orcid":false,"given":"Lucilla","family":"Fabbri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Lagadec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0549-4946","authenticated-orcid":false,"given":"Eva","family":"Gu\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Lecourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7257-8408","authenticated-orcid":false,"given":"Doroth\u00e9e","family":"Baille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3535-7723","authenticated-orcid":false,"given":"C\u00e9dric","family":"Messaoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"D\u00e9saubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Abou-Hamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9v\u00e9rine","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9rang\u00e8re","family":"Lombard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9111-8842","authenticated-orcid":false,"given":"Damarys","family":"Loew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1604-6823","authenticated-orcid":false,"given":"Jean-Yves","family":"Scoazec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9493-0238","authenticated-orcid":false,"given":"Caroline","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1452-7164","authenticated-orcid":false,"given":"St\u00e9phan","family":"Vagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"479_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc7480","volume":"14","author":"M Ali","year":"2022","unstructured":"Ali M, Lu M, Ang HX, Soderquist RS, Eyler CE, Hutchinson HM, Glass C, Bassil CF, Lopez OM, Kerr DL et al (2022) Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells. Sci Transl Med 14:eabc7480","journal-title":"Sci Transl Med"},{"key":"479_CR2","doi-asserted-by":"publisher","first-page":"18767","DOI":"10.1073\/pnas.1203853109","volume":"109","author":"M Badura","year":"2012","unstructured":"Badura M, Braunstein S, Zavadil J, Schneider RJ (2012) DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs. Proc Natl Acad Sci USA 109:18767\u201318772","journal-title":"Proc Natl Acad Sci USA"},{"key":"479_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG et al (2017) QuPath: Open source software for digital pathology image analysis. Sci Rep 7:16878","journal-title":"Sci Rep"},{"key":"479_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/sj.bjc.6605201","volume":"101","author":"C Beskow","year":"2009","unstructured":"Beskow C, Skikuniene J, Holgersson A, Nilsson B, Lewensohn R, Kanter L, Viktorsson K (2009) Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86. Br J Cancer 101:816\u2013821","journal-title":"Br J Cancer"},{"key":"479_CR5","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.18632\/oncotarget.1157","volume":"4","author":"L Bonanno","year":"2013","unstructured":"Bonanno L, Costa C, Majem M, Sanchez JJ, Gimenez-Capitan A, Rodriguez I, Vergnenegre A, Massuti B, Favaretto A, Rugge M et al (2013) The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy. Oncotarget 4:1572\u20131581","journal-title":"Oncotarget"},{"key":"479_CR6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.ijrobp.2012.02.014","volume":"84","author":"P Bouchaert","year":"2012","unstructured":"Bouchaert P, Guerif S, Debiais C, Irani J, Fromont G (2012) DNA-PKcs expression predicts response to radiotherapy in prostate cancer. Int J Radiat Oncol Biol Phys 84:1179\u20131185","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"479_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13572","volume":"513","author":"L Boussemart","year":"2014","unstructured":"Boussemart L, Malka-Mahieu H, Girault I, Allard D, Hemmingsson O, Tomasic G, Thomas M, Basmadjian C, Ribeiro N, Thuaud F et al (2014) eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies. Nature 513:105\u2013109","journal-title":"Nature"},{"key":"479_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nsmb.1831","volume":"17","author":"P Bouwman","year":"2010","unstructured":"Bouwman P, Aly A, Escandell JM, Pieterse M, Bartkova J, van der Gulden H, Hiddingh S, Thanasoula M, Kulkarni A, Yang Q et al (2010) 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct Mol Biol 17:688\u2013695","journal-title":"Nat Struct Mol Biol"},{"key":"479_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41594-023-01196-0","volume":"31","author":"J Brito Querido","year":"2024","unstructured":"Brito Querido J, Sokabe M, D\u00edaz-L\u00f3pez I, Gordiyenko Y, Fraser CS, Ramakrishnan V (2024) The structure of a human translation initiation complex reveals two independent roles for the helicase eIF4A. Nat Struct Mol Biol 31:455\u2013464","journal-title":"Nat Struct Mol Biol"},{"key":"479_CR10","doi-asserted-by":"publisher","first-page":"16793","DOI":"10.18632\/oncotarget.7589","volume":"7","author":"A Cammas","year":"2016","unstructured":"Cammas A, Lacroix-Triki M, Pierredon S, Le Bras M, Iacovoni JS, Teulade-Fichou MP, Favre G, Roch\u00e9 H, Filleron T, Millevoi S et al (2016) hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression. Oncotarget 7:16793\u201316805","journal-title":"Oncotarget"},{"key":"479_CR11","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1091\/mbc.e07-06-0603","volume":"18","author":"A Cammas","year":"2007","unstructured":"Cammas A, Pileur F, Bonnal S, Lewis SM, L\u00e9v\u00eaque N, Holcik M, Vagner S (2007) Cytoplasmic relocalization of heterogeneous nuclear ribonucleoprotein A1 controls translation initiation of specific mRNAs. Mol Biol Cell 18:5048\u20135059","journal-title":"Mol Biol Cell"},{"key":"479_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-025-08974-4","volume":"642","author":"T Ca\u00f1eque","year":"2025","unstructured":"Ca\u00f1eque T, Baron L, M\u00fcller S, Carmona A, Colombeau L, Versini A, Solier S, Gaillet C, Sindikubwabo F, Sampaio JL et al (2025) Activation of lysosomal iron triggers ferroptosis in cancer. Nature 642:492\u2013500","journal-title":"Nature"},{"key":"479_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30641-9","volume":"13","author":"H Chauvistr\u00e9","year":"2022","unstructured":"Chauvistr\u00e9 H, Shannan B, Daignault-Mill SM, Ju RJ, Picard D, Egetemaier S, V\u00e1raljai R, Gibhardt CS, Sechi A, Kaschani F et al (2022) Persister state-directed transitioning and vulnerability in melanoma. Nat Commun 13:3055","journal-title":"Nat Commun"},{"key":"479_CR14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1126\/science.aau8768","volume":"368","author":"A Cipponi","year":"2020","unstructured":"Cipponi A, Goode DL, Bedo J, McCabe MJ, Pajic M, Croucher DR, Rajal AG, Junankar SR, Saunders DN, Lobachevsky P et al (2020) MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer. Science 368:1127\u20131131","journal-title":"Science"},{"key":"479_CR15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954","journal-title":"Nature"},{"key":"479_CR16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1158\/2159-8290.CD-22-0787","volume":"13","author":"P Dharanipragada","year":"2023","unstructured":"Dharanipragada P, Zhang X, Liu S, Lomeli SH, Hong A, Wang Y, Yang Z, Lo KZ, Vega-Crespo A, Ribas A et al (2023) Blocking genomic instability prevents acquired resistance to MAPK inhibitor therapy in melanoma. Cancer Discov 13:880\u2013909","journal-title":"Cancer Discov"},{"key":"479_CR17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1158\/2159-8290.CD-13-0907","volume":"4","author":"F Dietlein","year":"2014","unstructured":"Dietlein F, Thelen L, Jokic M, Jachimowicz RD, Ivan L, Knittel G, Leeser U, van Oers J, Edelmann W, Heukamp LC et al (2014) A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDC. Cancer Discov 4:592\u2013605","journal-title":"Cancer Discov"},{"key":"479_CR18","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.1021\/acs.jmedchem.0c00182","volume":"63","author":"JT Ernst","year":"2020","unstructured":"Ernst JT, Thompson PA, Nilewski C, Sprengeler PA, Sperry S, Packard G, Michels T, Xiang A, Tran C, Wegerski CJ et al (2020) Design of development candidate eFT226, a first in class inhibitor of eukaryotic initiation factor 4A RNA Helicase. J Med Chem 63:5879\u20135955","journal-title":"J Med Chem"},{"key":"479_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1758834015616934","volume":"8","author":"Z Eroglu","year":"2016","unstructured":"Eroglu Z, Ribas A (2016) Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy. Ther Adv Med Oncol 8:48\u201356","journal-title":"Ther Adv Med Oncol"},{"key":"479_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41568-021-00380-y","volume":"21","author":"L Fabbri","year":"2021","unstructured":"Fabbri L, Chakraborty A, Robert C, Vagner S (2021) The plasticity of mRNA translation during cancer progression and therapy resistance. Nat Rev Cancer 21:558\u2013577","journal-title":"Nat Rev Cancer"},{"key":"479_CR21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.15252\/msb.20166796","volume":"13","author":"M Fallahi-Sichani","year":"2017","unstructured":"Fallahi-Sichani M, Becker V, Izar B, Baker GJ, Lin JR, Boswell SA, Shah P, Rotem A, Garraway LA, Sorger PK (2017) Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de-differentiated state. Mol Syst Biol 13:905","journal-title":"Mol Syst Biol"},{"key":"479_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1101\/gad.290940.116","volume":"31","author":"P Falletta","year":"2017","unstructured":"Falletta P, Sanchez-Del-Campo L, Chauhan J, Effern M, Kenyon A, Kershaw CJ, Siddaway R, Lisle R, Freter R, Daniels MJ et al (2017) Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma. Genes Dev 31:18\u201333","journal-title":"Genes Dev"},{"key":"479_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.766298","volume":"11","author":"A Gerson-Gurwitz","year":"2021","unstructured":"Gerson-Gurwitz A, Young NP, Goel VK, Eam B, Stumpf CR, Chen J, Fish S, Barrera M, Sung E, Staunton J et al (2021) Zotatifin, an eIF4A-selective inhibitor, blocks tumor growth in receptor tyrosine kinase driven tumors. Front Oncol 11:766298","journal-title":"Front Oncol"},{"key":"479_CR24","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/carcin\/19.11.1931","volume":"19","author":"WE Glaab","year":"1998","unstructured":"Glaab WE, Risinger JI, Umar A, Barrett JC, Kunkel TA, Tindall KR (1998) Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus. Carcinogenesis 19:1931\u20131937","journal-title":"Carcinogenesis"},{"key":"479_CR25","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1158\/2159-8290.CD-13-0108","volume":"3","author":"JF Goodwin","year":"2013","unstructured":"Goodwin JF, Schiewer MJ, Dean JL, Schrecengost RS, de Leeuw R, Han S, Ma T, Den RB, Dicker AP, Feng FY et al (2013) A hormone-DNA repair circuit governs the response to genotoxic insult. Cancer Discov 3:1254\u20131271","journal-title":"Cancer Discov"},{"key":"479_CR26","doi-asserted-by":"publisher","first-page":"e92444","DOI":"10.1371\/journal.pone.0092444","volume":"9","author":"C Guzm\u00e1n","year":"2014","unstructured":"Guzm\u00e1n C, Bagga M, Kaur A, Westermarck J, Abankwa D (2014) ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays. PLoS ONE 9:e92444","journal-title":"PLoS ONE"},{"key":"479_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, Galeas J, Dhruv HD, Berens ME, Schreiber SL et al (2017) Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 551:247\u2013250","journal-title":"Nature"},{"key":"479_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nm.4040","volume":"22","author":"AN Hata","year":"2016","unstructured":"Hata AN, Niederst MJ, Archibald HL, Gomez-Caraballo M, Siddiqui FM, Mulvey HE, Maruvka YE, Ji F, Bhang HE, Krishnamurthy Radhakrishna V et al (2016) Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition. Nat Med 22:262\u2013269","journal-title":"Nat Med"},{"key":"479_CR29","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1126\/science.aad9868","volume":"352","author":"AG Hinnebusch","year":"2016","unstructured":"Hinnebusch AG, Ivanov IP, Sonenberg N (2016) Translational control by 5\u2019-untranslated regions of eukaryotic mRNAs. Science 352:1413\u20131416","journal-title":"Science"},{"key":"479_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncb3452","volume":"19","author":"N Hustedt","year":"2016","unstructured":"Hustedt N, Durocher D (2016) The control of DNA repair by the cell cycle. Nat Cell Biol 19:1\u20139","journal-title":"Nat Cell Biol"},{"key":"479_CR31","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1093\/nar\/gkn649","volume":"36","author":"S Iiizumi","year":"2008","unstructured":"Iiizumi S, Kurosawa A, So S, Ishii Y, Chikaraishi Y, Ishii A, Koyama H, Adachi N (2008) Impact of non-homologous end-joining deficiency on random and targeted DNA integration: implications for gene targeting. Nucleic Acids Res 36:6333\u20136342","journal-title":"Nucleic Acids Res"},{"key":"479_CR32","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2011.10.002","volume":"147","author":"NT Ingolia","year":"2011","unstructured":"Ingolia NT, Lareau LF, Weissman JS (2011) Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147:789\u2013802","journal-title":"Cell"},{"key":"479_CR33","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nature17978","volume":"534","author":"S Iwasaki","year":"2016","unstructured":"Iwasaki S, Floor SN, Ingolia NT (2016) Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor. Nature 534:558\u2013561","journal-title":"Nature"},{"key":"479_CR34","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.molcel.2018.11.026","volume":"73","author":"S Iwasaki","year":"2019","unstructured":"Iwasaki S, Iwasaki W, Takahashi M, Sakamoto A, Watanabe C, Shichino Y, Floor SN, Fujiwara K, Mito M, Dodo K et al (2019) The translation inhibitor rocaglamide targets a bimolecular cavity between eIF4A and polypurine RNA. Mol Cell 73:738\u2013748.e739","journal-title":"Mol Cell"},{"key":"479_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10994","volume":"7","author":"S Jun","year":"2016","unstructured":"Jun S, Jung YS, Suh HN, Wang W, Kim MJ, Oh YS, Lien EM, Shen X, Matsumoto Y, McCrea PD et al (2016) LIG4 mediates Wnt signalling-induced radioresistance. Nat Commun 7:10994","journal-title":"Nat Commun"},{"key":"479_CR36","doi-asserted-by":"publisher","unstructured":"Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A (2021) Fast gene set enrichmentanalysis. Preprint at bioRxivhttps:\/\/doi.org\/10.1101\/060012","DOI":"10.1101\/060012"},{"key":"479_CR37","first-page":"321","volume":"24","author":"TC Lai","year":"2010","unstructured":"Lai TC, Chow KC, Lin TY, Chiang IP, Fang HY, Chen CY, Ho SP (2010) Expression of 53BP1 as a cisplatin-resistant marker in patients with lung adenocarcinomas. Oncol Rep 24:321\u2013328","journal-title":"Oncol Rep"},{"key":"479_CR38","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1158\/1535-7163.MCT-22-0037","volume":"21","author":"SL Lehman","year":"2022","unstructured":"Lehman SL, Wechsler T, Schwartz K, Brown LE, Porco JA, Devine WG, Pelletier J, Shankavaram UT, Camphausen K, Tofilon PJ (2022) Inhibition of the translation initiation factor eIF4A enhances tumor cell radiosensitivity. Mol Cancer Ther 21:1406\u20131414","journal-title":"Mol Cancer Ther"},{"key":"479_CR39","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrm1202","volume":"4","author":"MR Lieber","year":"2003","unstructured":"Lieber MR, Ma Y, Pannicke U, Schwarz K (2003) Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol 4:712\u2013720","journal-title":"Nat Rev Mol Cell Biol"},{"key":"479_CR40","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1158\/0008-5472.CAN-07-5876","volume":"68","author":"CJ Lin","year":"2008","unstructured":"Lin CJ, Cencic R, Mills JR, Robert F, Pelletier J (2008) c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. Cancer Res 68:5326\u20135334","journal-title":"Cancer Res"},{"key":"479_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrc.2015.21","volume":"16","author":"CJ Lord","year":"2016","unstructured":"Lord CJ, Ashworth A (2016) BRCAness revisited. Nat Rev Cancer 16:110\u2013120","journal-title":"Nat Rev Cancer"},{"key":"479_CR42","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1158\/2159-8290.CD-18-0879","volume":"9","author":"O Maertens","year":"2019","unstructured":"Maertens O, Kuzmickas R, Manchester HE, Emerson CE, Gavin AG, Guild CJ, Wong TC, De Raedt T, Bowman-Colin C, Hatchi E et al (2019) MAPK pathway suppression unmasks latent DNA repair defects and confers a chemical synthetic vulnerability in BRAF-, NRAS-, and NF1-mutant melanomas. Cancer Discov 9:526\u2013545","journal-title":"Cancer Discov"},{"key":"479_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2702-y","volume":"11","author":"E Makino","year":"2020","unstructured":"Makino E, Fr\u00f6hlich LM, Sinnberg T, Kosnopfel C, Sauer B, Garbe C, Schittek B (2020) Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition. Cell Death Dis 11:581","journal-title":"Cell Death Dis"},{"key":"479_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1158\/1078-0432.CCR-14-2362","volume":"23","author":"H Malka-Mahieu","year":"2017","unstructured":"Malka-Mahieu H, Newman M, D\u00e9saubry L, Robert C, Vagner S (2017) Molecular pathways: the eIF4F translation initiation complex-new opportunities for cancer treatment. Clin Cancer Res 23:21\u201325","journal-title":"Clin Cancer Res"},{"key":"479_CR45","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","volume":"20","author":"JC Marine","year":"2020","unstructured":"Marine JC, Dawson SJ, Dawson MA (2020) Non-genetic mechanisms of therapeutic resistance in cancer. Nat Rev Cancer 20:743\u2013756","journal-title":"Nat Rev Cancer"},{"key":"479_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101255","volume":"4","author":"DJ McGrail","year":"2023","unstructured":"McGrail DJ, Li Y, Smith RS, Feng B, Dai H, Hu L, Dennehey B, Awasthi S, Mendillo ML, Sood AK et al (2023) Widespread BRCA1\/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins. Cell Rep Med 4:101255","journal-title":"Cell Rep Med"},{"key":"479_CR47","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1158\/1078-0432.CCR-12-0052","volume":"18","author":"AM Menzies","year":"2012","unstructured":"Menzies AM, Haydu LE, Visintin L, Carlino MS, Howle JR, Thompson JF, Kefford RF, Scolyer RA, Long GV (2012) Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma. Clin Cancer Res 18:3242\u20133249","journal-title":"Clin Cancer Res"},{"key":"479_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60228-z","volume":"16","author":"L Mi","year":"2025","unstructured":"Mi L, Cai Y, Qi J, Chen L, Li Y, Zhang S, Ran H, Qi Q, Zhang C, Wu H et al (2025) Elevated nonhomologous end-joining by AATF enables efficient DNA damage repair and therapeutic resistance in glioblastoma. Nat Commun 16:4941","journal-title":"Nat Commun"},{"key":"479_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32517-9","volume":"8","author":"MA Miles","year":"2018","unstructured":"Miles MA, Hawkins CJ (2018) Mutagenic assessment of chemotherapy and Smac mimetic drugs in cells with defective DNA damage response pathways. Sci Rep 8:14421","journal-title":"Sci Rep"},{"key":"479_CR50","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1038\/s44319-025-00443-3","volume":"26","author":"G Mohanan","year":"2025","unstructured":"Mohanan G, Roy R, Malka-Mahieu H, Lamba S, Fabbri L, Kalia S, Biswas A, Martineau S, C ML, Vagner S et al (2025) Genotoxic stress triggers Scd6-dependent regulation of translation to modulate the DNA damage response. EMBO Rep 26:2715\u20132739","journal-title":"EMBO Rep"},{"key":"479_CR51","doi-asserted-by":"publisher","first-page":"e121951","DOI":"10.1172\/jci.insight.121951","volume":"4","author":"D M\u00fcller","year":"2019","unstructured":"M\u00fcller D, Shin S, Goullet de Rugy T, Samain R, Baer R, Strehaiano M, Masvidal-Sanz L, Guillermet-Guibert J, Jean C, Tsukumo Y et al (2019) eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer. JCI Insight 4:e121951","journal-title":"JCI Insight"},{"key":"479_CR52","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09626","volume":"468","author":"R Nazarian","year":"2010","unstructured":"Nazarian R, Shi H, Wang Q, Kong X, Koya RC, Lee H, Chen Z, Lee MK, Attar N, Sazegar H et al (2010) Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature 468:973\u2013977","journal-title":"Nature"},{"key":"479_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrm3719","volume":"15","author":"S Panier","year":"2014","unstructured":"Panier S, Boulton SJ (2014) Double-strand break repair: 53BP1 comes into focus. Nat Rev Mol Cell Biol 15:7\u201318","journal-title":"Nat Rev Mol Cell Biol"},{"key":"479_CR54","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1073\/pnas.1013715108","volume":"108","author":"AG Patel","year":"2011","unstructured":"Patel AG, Sarkaria JN, Kaufmann SH (2011) Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells. Proc Natl Acad Sci USA 108:3406\u20133411","journal-title":"Proc Natl Acad Sci USA"},{"key":"479_CR55","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-biochem-013118-111042","volume":"88","author":"J Pelletier","year":"2019","unstructured":"Pelletier J, Sonenberg N (2019) The organizing principles of eukaryotic ribosome recruitment. Annu Rev Biochem 88:307\u2013335","journal-title":"Annu Rev Biochem"},{"key":"479_CR56","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1002\/pmic.200600784","volume":"7","author":"P Poullet","year":"2007","unstructured":"Poullet P, Carpentier S, Barillot E (2007) myProMS, a web server for management and validation of mass spectrometry-based proteomic data. Proteomics 7:2553\u20132556","journal-title":"Proteomics"},{"key":"479_CR57","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","volume":"174","author":"F Rambow","year":"2018","unstructured":"Rambow F, Rogiers A, Marin-Bejar O, Aibar S, Femel J, Dewaele M, Karras P, Brown D, Chang YH, Debiec-Rychter M et al (2018) Toward minimal residual disease-directed therapy in melanoma. Cell 174:843\u2013855.e819","journal-title":"Cell"},{"key":"479_CR58","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41586-018-0243-7","volume":"558","author":"F Rapino","year":"2018","unstructured":"Rapino F, Delaunay S, Rambow F, Zhou Z, Tharun L, De Tullio P, Sin O, Shostak K, Schmitz S, Piepers J et al (2018) Codon-specific translation reprogramming promotes resistance to targeted therapy. Nature 558:605\u2013609","journal-title":"Nature"},{"key":"479_CR59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/NEJMoa1412690","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Karaszewska B, Schachter J, Rutkowski P, Mackiewicz A, Stroiakovski D, Lichinitser M, Dummer R, Grange F, Mortier L et al (2015) Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med 372:30\u201339","journal-title":"N Engl J Med"},{"key":"479_CR60","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","volume":"23","author":"A Roesch","year":"2013","unstructured":"Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann KM, Speicher D, K\u00f6rbel C, Laschke MW, Gimotty PA, Philipp SE et al (2013) Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell 23:811\u2013825","journal-title":"Cancer Cell"},{"key":"479_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19502-5","volume":"11","author":"MB Rother","year":"2020","unstructured":"Rother MB, Pellegrino S, Smith R, Gatti M, Meisenberg C, Wiegant WW, Luijsterburg MS, Imhof R, Downs JA, Vertegaal ACO et al (2020) CHD7 and 53BP1 regulate distinct pathways for the re-ligation of DNA double-strand breaks. Nat Commun 11:5775","journal-title":"Nat Commun"},{"key":"479_CR62","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","volume":"24","author":"M Russo","year":"2024","unstructured":"Russo M, Chen M, Mariella E, Peng H, Rehman SK, Sancho E, Sogari A, Toh TS, Balaban NQ, Batlle E et al (2024) Cancer drug-tolerant persister cells: from biological questions to clinical opportunities. Nat Rev Cancer 24:694\u2013717","journal-title":"Nat Rev Cancer"},{"key":"479_CR63","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1126\/science.aav4474","volume":"366","author":"M Russo","year":"2019","unstructured":"Russo M, Crisafulli G, Sogari A, Reilly NM, Arena S, Lamba S, Bartolini A, Amodio V, Magr\u00ec A, Novara L et al (2019) Adaptive mutability of colorectal cancers in response to targeted therapies. Science 366:1473\u20131480","journal-title":"Science"},{"key":"479_CR64","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41588-022-01105-z","volume":"54","author":"M Russo","year":"2022","unstructured":"Russo M, Pompei S, Sogari A, Corigliano M, Crisafulli G, Puliafito A, Lamba S, Erriquez J, Bertotti A, Gherardi M et al (2022) A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells. Nat Genet 54:976\u2013984","journal-title":"Nat Genet"},{"key":"479_CR65","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682","journal-title":"Nat Methods"},{"key":"479_CR66","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature22794","volume":"546","author":"SM Shaffer","year":"2017","unstructured":"Shaffer SM, Dunagin MC, Torborg SR, Torre EA, Emert B, Krepler C, Beqiri M, Sproesser K, Brafford PA, Xiao M et al (2017) Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546:431\u2013435","journal-title":"Nature"},{"key":"479_CR67","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","volume":"141","author":"SV Sharma","year":"2010","unstructured":"Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach MA et al (2010) A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141:69\u201380","journal-title":"Cell"},{"key":"479_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13360-6","volume":"10","author":"S Shen","year":"2019","unstructured":"Shen S, Faouzi S, Bastide A, Martineau S, Malka-Mahieu H, Fu Y, Sun X, Mateus C, Routier E, Roy S et al (2019) An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells. Nat Commun 10:5713","journal-title":"Nat Commun"},{"key":"479_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28705-x","volume":"13","author":"LK Smith","year":"2022","unstructured":"Smith LK, Parmenter T, Kleinschmidt M, Kusnadi EP, Kang J, Martin CA, Lau P, Patel R, Lorent J, Papadopoli D et al (2022) Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF(V600) melanoma. Nat Commun 13:1100","journal-title":"Nat Commun"},{"key":"479_CR70","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.molcel.2010.09.028","volume":"40","author":"KA Spriggs","year":"2010","unstructured":"Spriggs KA, Bushell M, Willis AE (2010) Translational regulation of gene expression during conditions of cell stress. Mol Cell 40:228\u2013237","journal-title":"Mol Cell"},{"key":"479_CR71","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer C, Wang T, Michaelos M, Pachitariu M (2021) Cellpose: a generalist algorithm for cellular segmentation. Nat Methods 18:100\u2013106","journal-title":"Nat Methods"},{"key":"479_CR72","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ccr.2010.11.023","volume":"18","author":"J Villanueva","year":"2010","unstructured":"Villanueva J, Vultur A, Lee JT, Somasundaram R, Fukunaga-Kalabis M, Cipolla AK, Wubbenhorst B, Xu X, Gimotty PA, Kee D et al (2010) Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R\/PI3K. Cancer Cell 18:683\u2013695","journal-title":"Cancer Cell"},{"key":"479_CR73","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1172\/JCI127483","volume":"130","author":"CE Willoughby","year":"2020","unstructured":"Willoughby CE, Jiang Y, Thomas HD, Willmore E, Kyle S, Wittner A, Phillips N, Zhao Y, Tudhope SJ, Prendergast L et al (2020) Selective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapy. J Clin Invest 130:258\u2013271","journal-title":"J Clin Invest"},{"key":"479_CR74","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature13485","volume":"513","author":"AL Wolfe","year":"2014","unstructured":"Wolfe AL, Singh K, Zhong Y, Drewe P, Rajasekhar VK, Sanghvi VR, Mavrakis KJ, Jiang M, Roderick JE, Van der Meulen J et al (2014) RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer. Nature 513:65\u201370","journal-title":"Nature"},{"key":"479_CR75","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, Tang W, Wang Q, Liu B, Wang R et al (2024) Using clusterProfiler to characterize multiomics data. Nat Protoc 19:3292\u20133320","journal-title":"Nat Protoc"},{"key":"479_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/science.add3067","volume":"380","author":"H Zeng","year":"2023","unstructured":"Zeng H, Huang J, Ren J, Wang CK, Tang Z, Zhou H, Zhou Y, Shi H, Aditham A, Sui X et al (2023) Spatially resolved single-cell translatomics at molecular resolution. Science 380:eadd3067","journal-title":"Science"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00479-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:32:07Z","timestamp":1786516327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00479-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":76,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,12]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00479-5","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}